IAO Public Policy

IAO initiatives impact on medical professionals, Life Science Professionals oncology specialists and cancer patients in various areas, including issues either directly related to cancer or to Public health in general:

• Access to care and to information
• Centres of reference
• Health Technology assessment
• Best practices
• Sharing resources and capacities
• Shortage of professionals
• Recognition of professional qualifications, etc.

IAO’s public policy activities support IAO and its members by engaging with the authorities on issues related to the practice and profession of medical oncology. They help IAO and its members in their mission and activities by providing specific support concerning political affairs.

IAO has a dynamically diverse and global reach.To inform and improve public policy IAO Public Policy Committee coordinates the association's activities. IAO seeks to educate policymakers, Medical Oncologists, and the public about policies that will foster and accelerate innovations in cancer treatment, Medical Oncology and related disciplines in ways that benefit society.

IAO provides independent and technology-neutral research and resources to policy leaders, stakeholders, and the public about public policy issues. IAO's contributions to public policy are drawn from the deep technical expertise of the Medical Oncology community. Our policy members apply their expertise and experience to bring relevant scientific research, best practices, and foresight of technology advances to public policy issues. Through policy statements, issue briefs, white papers, and reports, IAO delivers knowledge-based analysis and educational materials to advance policy leaders' understanding.

Highlights of Our Public Policy Activities

IAO provides independent and technology-neutral research and resources to policy leaders, other stakeholders, and the public about public policy issues, drawn from the deep expertise of the Medical Oncology community.

• Our activities are covered by media outlets from all across the world.
• We publish a Bi-annual newsletter on policy issues for audiences around the world.
• We reached 10,000+ users through our blog and social media.
• We educated 200+ congressional staff and policy leaders during this past year through our briefings, events, and webinars.
• We contributed to multi stakeholder discussions as panel speakers, discussants, and advisory experts.
• We provide comments responsive to proposed regulations with far-reaching implications for the Medical Oncology field and society.
• We provide thought-leadership on cutting-edge technology policy issues.
• We provide detailed, analytical, scientifically sound, and technically accurate policy recommendations and analysis to high-level federal decision makers from all over the world